LifeStance Health Group Inc. (NASDAQ: LFST) announced the pricing of a secondary public offering of 35 million shares of common stock at $8.15 per share. The shares are being sold by existing stockholders, with the company not receiving any proceeds from the offering.

The mental health care provider will separately purchase 6 million shares from the offering at the same price paid by the underwriter to the selling stockholders. This repurchase is contingent on the completion of the offering and other standard conditions, though the offering itself does not depend on the repurchase.

J.P. Morgan Securities is serving as the underwriter for the transaction. The offering and repurchase are expected to close on or around May 12, 2026, subject to customary closing conditions.

The company operates as one of the largest providers of virtual and in-person outpatient mental health services in the United States. LifeStance employs over 8,300 psychiatrists, advanced practice nurses, psychologists and therapists across 33 states and more than 550 centers.

The offering is being conducted under a shelf registration statement filed with the Securities and Exchange Commission on May 21, 2024, which became effective upon filing.